Serrapeptase and Biofilms: The Systemic Protein Cleanser
Exploring the fibrinolytic and anti-biofilm properties of Serrapeptase, a proteolytic enzyme with profound implications for systemic inflammation and chronic infection.
Serrapeptase and Biofilms: The Systemic Protein Cleanser
Serrapeptase (also known as serratiopeptidase) is a proteolytic enzyme originally discovered in the digestive tract of the silkworm. While the silkworm uses it to dissolve its tough silk cocoon, in human physiology, serrapeptase has gained recognition as a powerful systemic enzyme capable of dissolving non-living tissue, reducing inflammation, and disrupting bacterial Biofilms.
Unlike digestive enzymes taken with food to aid nutrient breakdown, serrapeptase is taken on an empty stomach to enter the bloodstream, where it acts as a molecular "cleanup crew" for the body's connective tissues and circulatory system.
1. The Fibrinolytic Mechanism: Dissolving the Scaffolding
Serrapeptase belongs to a class of enzymes called fibrinolytics. Its primary target is Fibrin, the tough, fibrous protein that forms the structural basis of blood clots, scar tissue, and arterial plaques.
Breaking Down Non-Living Tissue
Serrapeptase has a unique affinity for non-living protein structures. It can selectively dissolve:
- Scar Tissue and Adhesions: By breaking down the cross-linked fibrin in old scars, it can help restore flexibility to tissues.
- Arterial Plaque: It assists in the gradual thinning of the proteinaceous "cap" of atherosclerotic plaques.
- Inflammatory Byproducts: It breaks down the bradykinin and other proteins that trigger pain and swelling at the site of an injury.